Ernexa Therapeutics Inc. (ERNA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-586.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $582.0K | $68.0K | $0 | — | $5.80M | $19.81M | $23.34M | $21.27M | $22.31M |
| Cost of Revenue | — | $96.0K | $236.0K | $0 | — | — | — | — | — | — |
| Gross Profit | — | $486.0K | -$168.0K | $0 | — | — | — | — | — | — |
| Operating Income | -$9.32M | -$15.67M | -$21.14M | -$33.22M | -$113.73M | -$7.25M | -$1.76M | $203.0K | -$1.40M | -$2.28M |
| Net Income | -$14.08M | -$44.54M | -$21.67M | -$24.58M | -$122.55M | -$7.29M | -$2.05M | -$259.0K | -$1.08M | -$2.92M |
| EPS (Diluted) | $-2.24 | $-48.96 | $-4.08 | $-8.06 | $-56.61 | $-0.41 | — | — | — | — |
| Total Assets | $5.83M | $5.27M | $49.13M | $22.28M | $31.52M | $12.91M | $14.12M | $14.86M | $16.57M | $16.70M |
| Total Liabilities | $3.43M | $3.57M | $46.90M | $10.17M | $6.02M | $5.25M | $9.03M | $7.95M | $11.03M | $12.63M |
| Shareholders' Equity | $2.40M | $1.70M | $2.23M | $12.11M | $25.50M | $7.66M | $9.74M | $6.92M | $5.54M | $4.07M |
| Cash & Equivalents | — | $1.73M | $7.58M | $11.45M | $16.98M | $777.0K | $3.21M | $2.54M | $3.38M | $5.69M |
| Operating Cash Flow | -$7.02M | -$15.84M | -$20.41M | -$20.98M | -$23.49M | -$8.10M | $2.74M | $1.36M | $549.0K | $23.0K |
| Capital Expenditures | $37.0K | $369.0K | $19.0K | $297.0K | $154.0K | $39.0K | $128.0K | $648.0K | $728.0K | $427.0K |
| Shares Outstanding | 7.85M | 3.43M | 5.41M | 5.13M | 2.60M | 0 | 2.90M | 2.88M | 2.52M | 2.26M |